Lifemd Inc Stock Alpha and Beta Analysis

LFMD Stock  USD 6.47  0.67  11.55%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as LifeMD Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in LifeMD over a specified time horizon. Remember, high LifeMD's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to LifeMD's market risk premium analysis include:
Beta
3.42
Alpha
(0.06)
Risk
5.73
Sharpe Ratio
0.0913
Expected Return
0.52
Please note that although LifeMD alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, LifeMD did 0.06  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of LifeMD Inc stock's relative risk over its benchmark. LifeMD Inc has a beta of 3.42  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LifeMD will likely underperform. At present, LifeMD's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 84.19, whereas Enterprise Value Over EBITDA is forecasted to decline to (34.11).

Enterprise Value

280.2 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out LifeMD Backtesting, LifeMD Valuation, LifeMD Correlation, LifeMD Hype Analysis, LifeMD Volatility, LifeMD History and analyze LifeMD Performance.

LifeMD Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. LifeMD market risk premium is the additional return an investor will receive from holding LifeMD long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in LifeMD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate LifeMD's performance over market.
α-0.06   β3.42

LifeMD expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of LifeMD's Buy-and-hold return. Our buy-and-hold chart shows how LifeMD performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

LifeMD Market Price Analysis

Market price analysis indicators help investors to evaluate how LifeMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LifeMD shares will generate the highest return on investment. By understating and applying LifeMD stock market price indicators, traders can identify LifeMD position entry and exit signals to maximize returns.

LifeMD Return and Market Media

The median price of LifeMD for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 5.06 with a coefficient of variation of 12.49. The daily time series for the period is distributed with a sample standard deviation of 0.63, arithmetic mean of 5.05, and mean deviation of 0.45. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Stefan Galluppi of 3000 shares of LifeMD at 4.93 subject to Rule 16b-3
09/11/2024
2
LifeMD executive buys 14,790 in company stock - Investing.com
09/12/2024
3
Disposition of 200000 shares by Marc Benathen of LifeMD at 21.2 subject to Rule 16b-3
09/18/2024
4
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
09/19/2024
5
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - StockTitan
09/24/2024
6
LifeMD shareholders are still up 522 percent over 5 years despite pulling back 11 percent in the past week
10/02/2024
7
LifeMD, Inc. Given Average Rating of Buy by Brokerages
10/15/2024
8
Medifast Announces Third Quarter 2024 Financial Results
11/04/2024
9
Earnings to Watch LifeMD Inc Reports Q3 2024 Result
11/06/2024
10
LifeMD Inc Q3 2024 Earnings Call Highlights Strong Telehealth Growth and Strategic ...
11/08/2024
11
LifeMD, Inc. Q3 2024 Earnings Call Transcript
11/11/2024

About LifeMD Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including LifeMD or other stocks. Alpha measures the amount that position in LifeMD Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 (projected)
Dividend Yield0.0083380.05170.0111
Price To Sales Ratio1.130.51.84

LifeMD Upcoming Company Events

As portrayed in its financial statements, the presentation of LifeMD's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LifeMD's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of LifeMD's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of LifeMD. Please utilize our Beneish M Score to check the likelihood of LifeMD's management manipulating its earnings.
27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with LifeMD

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out LifeMD Backtesting, LifeMD Valuation, LifeMD Correlation, LifeMD Hype Analysis, LifeMD Volatility, LifeMD History and analyze LifeMD Performance.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
LifeMD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of LifeMD technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of LifeMD trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...